Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice

被引:0
|
作者
Li, Hui [1 ]
Fang, Yujiao [1 ,2 ]
Wang, Da [1 ,2 ]
Shi, Bowen [1 ,2 ]
Thompson, Garth J. [1 ]
机构
[1] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China
[2] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源
NUTRITION & DIABETES | 2024年 / 14卷 / 01期
基金
中国国家自然科学基金;
关键词
RESTING-STATE FMRI; REDUCES FOOD-INTAKE; FUNCTIONAL CONNECTIVITY; GLOBAL SIGNAL; F-18-FDG PET; IN-VIVO; GLP-1; MRI; DIAGNOSIS;
D O I
10.1038/s41387-024-00343-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Quantitative mapping of the brain's metabolism is a critical tool in studying and diagnosing many conditions, from obesity to neurodegenerative diseases. In particular, noninvasive approaches are urgently required. Recently, there have been promising drug development approaches for the treatment of disorders related to glucose metabolism in the brain and, therefore, against obesity-associated diseases. One of the most important drug targets to emerge has been the Glucagon-like peptide-1 (GLP-1) and its receptor (GLP-1R). GLP and GLP-1R play an important role in regulating blood sugar and maintaining energy homeostasis. However, the macroscopic effects on brain metabolism and function due to the presence of GLP-1R are unclear. Methods To explore the physiological role of GLP-1R in mouse brain glucose metabolism, and its relationship to brain function, we used three methods. We used deuterium magnetic resonance spectroscopy (DMRS) to provide quantitative information about metabolic flux, fluorodeoxyglucose positron emission tomography (FDG-PET) to measure brain glucose metabolism, and resting state-functional MRI (rs-fMRI) to measure brain functional connectivity. We used these methods in both mice with complete GLP-1R knockout (GLP-1R KO) and wild-type C57BL/6N (WT) mice. Results The metabolic rate of GLP-1R KO mice was significantly slower than that of WT mice (p = 0.0345, WT mice 0.02335 +/- 0.057 mM/min, GLP-1R KO mice 0.01998 +/- 0.07 mM/min). Quantification of the mean [18F]FDG signal in the whole brain also showed significantly reduced glucose uptake in GLP-1R KO mice versus control mice (p = 0.0314). Observing rs-fMRI, the functional brain connectivity in GLP-1R KO mice was significantly lower than that in the WT group (p = 0.0032 for gFCD, p = 0.0002 for whole-brain correlation, p < 0.0001 for ALFF). Conclusions GLP-1R KO mice exhibit impaired brain glucose metabolism to high doses of exogenous glucose, and they also have reduced functional connectivity. This suggests that the GLP-1R KO mouse model may serve as a model for correlated metabolic and functional connectivity loss.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism
    Huang, Zhaohuan
    Liu, Ling
    Zhang, Jian
    Conde, Kristie
    Phansalkar, Jay
    Li, Zhongzhong
    Yao, Lei
    Xu, Zihui
    Wang, Wei
    Zhou, Jiangning
    Bi, Guoqiang
    Wu, Feng
    Seeley, Randy J.
    Scott, Michael M.
    Zhan, Cheng
    Pang, Zhiping P.
    Liu, Ji
    SCIENCE ADVANCES, 2022, 8 (23)
  • [22] Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs
    Nishizawa, M
    Moore, MC
    Shiota, M
    Gustavson, SM
    Snead, WL
    Neal, DW
    Cherrington, AD
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (05): : E1027 - E1036
  • [23] Glucagon-like peptide-1, glucose homeostasis and diabetes
    Holst, Jens J.
    Deacon, Carolyn F.
    Vilsboll, Tina
    Krarup, Thure
    Madsbad, Sten
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) : 161 - 168
  • [24] Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
    Cho, Young Min
    Fujita, Yukihiro
    Kieffer, Timothy J.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 76, 2014, 76 : 535 - 559
  • [25] Cellular glucose availability and glucagon-like peptide-1
    Park, Jae-Hyung
    Earm, Yung E.
    Song, Dae-Kyu
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2011, 107 (02): : 286 - 292
  • [26] Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects
    Murakami, Takaaki
    Fujimoto, Hiroyuki
    Fujita, Naotaka
    Hamamatsu, Keita
    Yabe, Daisuke
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1448 - 1456
  • [27] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399
  • [28] Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
    Zhang, Fang
    Tang, Xialian
    Cao, Hongyi
    Lu, Qingguo
    Li, Nali
    Liu, Yupu
    Zhang, Xiangxun
    Zhang, Yuwei
    Cao, Mingming
    Wan, Jun
    An, Zhenmei
    Tong, Nanwei
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (07): : 574 - 581
  • [29] Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes
    Luque, MA
    González, N
    Márquez, L
    Acitores, A
    Redondo, A
    Morales, M
    Valverde, I
    Villanueva-Peñacarrillo, ML
    JOURNAL OF ENDOCRINOLOGY, 2002, 173 (03) : 465 - 473
  • [30] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554